K. Aaron Geno, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, Moon H. Nahm: Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews, 2015-07, 28. vsk, nro 3, s. 871–899. PubMed:26085553. doi:10.1128/CMR.00024-15. ISSN 0893-8512. Artikkelin verkkoversio. en
Shahan Syed, Eija Nissilä, Hanna Ruhanen, Satoshi Fudo, Meztlli O. Gaytán, Sanna P. Sihvo: Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience, 25.6.2021, 24. vsk, nro 6. PubMed:34124613. doi:10.1016/j.isci.2021.102535. ISSN 2589-0042. Artikkelin verkkoversio. English
Kevin S. Ikuta et al. (GBD 2019 Antimicrobial Resistance Collaborators): Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 21.11.2022. doi:10.1016/S0140-6736(22)02185-7. Artikkelin verkkoversio. Viitattu 24.11.2022. (englanniksi)
K. Aaron Geno, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, Moon H. Nahm: Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews, 2015-07, 28. vsk, nro 3, s. 871–899. PubMed:26085553. doi:10.1128/CMR.00024-15. ISSN 0893-8512. Artikkelin verkkoversio. en
Shahan Syed, Eija Nissilä, Hanna Ruhanen, Satoshi Fudo, Meztlli O. Gaytán, Sanna P. Sihvo: Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience, 25.6.2021, 24. vsk, nro 6. PubMed:34124613. doi:10.1016/j.isci.2021.102535. ISSN 2589-0042. Artikkelin verkkoversio. English
Sam Mehr, Nicholas Wood: Streptococcus pneumoniae – a review of carriage, infection, serotype replacement and vaccination. Paediatric Respiratory Reviews, 2012-12, nro 4, s. 258–264. doi:10.1016/j.prrv.2011.12.001. Artikkelin verkkoversio. en
Amy V. Paschall, Dustin R. Middleton, Paeton L. Wantuch, Fikri Y. Avci: Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase. Pharmaceutical Research, 2020-12, nro 12, s. 236. PubMed:33140159. doi:10.1007/s11095-020-02960-3. ISSN 0724-8741. Artikkelin verkkoversio. en
elsevier.com
linkinghub.elsevier.com
Sam Mehr, Nicholas Wood: Streptococcus pneumoniae – a review of carriage, infection, serotype replacement and vaccination. Paediatric Respiratory Reviews, 2012-12, nro 4, s. 258–264. doi:10.1016/j.prrv.2011.12.001. Artikkelin verkkoversio. en
K. Aaron Geno, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, Moon H. Nahm: Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews, 2015-07, 28. vsk, nro 3, s. 871–899. PubMed:26085553. doi:10.1128/CMR.00024-15. ISSN 0893-8512. Artikkelin verkkoversio. en
Shahan Syed, Eija Nissilä, Hanna Ruhanen, Satoshi Fudo, Meztlli O. Gaytán, Sanna P. Sihvo: Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience, 25.6.2021, 24. vsk, nro 6. PubMed:34124613. doi:10.1016/j.isci.2021.102535. ISSN 2589-0042. Artikkelin verkkoversio. English
Amy V. Paschall, Dustin R. Middleton, Paeton L. Wantuch, Fikri Y. Avci: Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase. Pharmaceutical Research, 2020-12, nro 12, s. 236. PubMed:33140159. doi:10.1007/s11095-020-02960-3. ISSN 0724-8741. Artikkelin verkkoversio. en
springer.com
link.springer.com
Amy V. Paschall, Dustin R. Middleton, Paeton L. Wantuch, Fikri Y. Avci: Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase. Pharmaceutical Research, 2020-12, nro 12, s. 236. PubMed:33140159. doi:10.1007/s11095-020-02960-3. ISSN 0724-8741. Artikkelin verkkoversio. en
thelancet.com
Kevin S. Ikuta et al. (GBD 2019 Antimicrobial Resistance Collaborators): Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 21.11.2022. doi:10.1016/S0140-6736(22)02185-7. Artikkelin verkkoversio. Viitattu 24.11.2022. (englanniksi)
K. Aaron Geno, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, Moon H. Nahm: Pneumococcal Capsules and Their Types: Past, Present, and Future. Clinical Microbiology Reviews, 2015-07, 28. vsk, nro 3, s. 871–899. PubMed:26085553. doi:10.1128/CMR.00024-15. ISSN 0893-8512. Artikkelin verkkoversio. en
Shahan Syed, Eija Nissilä, Hanna Ruhanen, Satoshi Fudo, Meztlli O. Gaytán, Sanna P. Sihvo: Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience, 25.6.2021, 24. vsk, nro 6. PubMed:34124613. doi:10.1016/j.isci.2021.102535. ISSN 2589-0042. Artikkelin verkkoversio. English
Amy V. Paschall, Dustin R. Middleton, Paeton L. Wantuch, Fikri Y. Avci: Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase. Pharmaceutical Research, 2020-12, nro 12, s. 236. PubMed:33140159. doi:10.1007/s11095-020-02960-3. ISSN 0724-8741. Artikkelin verkkoversio. en